FGFR1OP anticorps (N-Term)

N° du produit ABIN632972

Détail du produit anti-FGFR1OP anticorps

Antigène: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Épitope: N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FGFR1OP est non-conjugé

Application: Western Blotting (WB)

Specificité: FGFR1 OP antibody was raised against the N terminal of FGFR1 P

Purification: Affinity purified

Immunogène: FGFR1 OP antibody was raised using the N terminal of FGFR1 P corresponding to a region with amino acids FLQFFNLDFTLAVFQPETSTLQGLEGRENLARDLGIIEAEGTVGGPLLLE

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

FGFR1OP Blocking Peptide, catalog no. 33R-2977, is also available for use as a blocking control in assays to test for specificity of this FGFR1OP antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FGFR0 P antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur FGFR1OP

Antigène: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Autre désignation: FGFR1OP (FGFR1OP Produits)

Synonymes: anticorps 4930553O10Rik, anticorps FOP, anticorps ccr6a, anticorps zgc:86782, anticorps fgfr1op, anticorps Fgfr1op, anticorps MGC132198, anticorps C1orf77, anticorps C3H1orf77, anticorps SRAG, anticorps Fgfr1 oncogene partner, anticorps FGFR1 oncogene partner, anticorps FGFR1 oncogene partner L homeolog, anticorps chromatin target of PRMT1, anticorps Fgfr1op, anticorps FGFR1OP, anticorps fgfr1op, anticorps fgfr1op.L, anticorps CHTOP

Sujet: FGFR1OP is a largely hydrophilic protein postulated to be a leucine-rich protein family member. A t (6,8)(q27,p11) chromosomal translocation, fusing this gene and the fibroblast growth factor receptor 1 (FGFR1) gene, has been found in cases of myeloproliferative disorder. The resulting chimeric protein contains the N-terminal leucine-rich region of this encoded protein fused to the catalytic domain of FGFR1. This gene is thought to play an important role in normal proliferation and differentiation of the erythroid lineage.

Poids moléculaire: 42 kDa (MW of target protein)

Pathways: M Phase, Maintenance of Protein Location, SARS-CoV-2 Protein Interactome